Condition
Sympathetic Nerve Activity
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (1)
P 3 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04934228Phase 1Recruiting
Mitigating the Pro-inflammatory Phenotype of Obesity
NCT03514823Not ApplicableCompleted
Respiratory Muscle Contribution to Blood Pressure During Exercise
NCT02264262Not ApplicableCompletedPrimary
Noninvasive Measurement of Sympathetic Nerve Activity in Healthy Volunteers
NCT02939469Phase 2WithdrawnPrimary
Skin Sympathetic Nerve Activity and Cardiac Arrhythmias
NCT01336335Phase 3Unknown
The Effects of Continuous Positive Airway Pressure (CPAP) on Sympathetic Activity in Different Sites of Activation
Showing all 5 trials